Veradigm (NASDAQ:MDRX) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX) in a research report report published on Monday. The firm issued a hold rating on the software maker’s stock.

Veradigm Stock Up 2.1 %

MDRX stock opened at $9.70 on Monday. The stock’s 50 day simple moving average is $9.65 and its 200 day simple moving average is $8.94. Veradigm has a fifty-two week low of $5.01 and a fifty-two week high of $14.09.

Hedge Funds Weigh In On Veradigm

A number of large investors have recently made changes to their positions in MDRX. Innealta Capital LLC purchased a new stake in Veradigm during the second quarter valued at about $38,000. Tyro Capital Management LLC bought a new stake in Veradigm during the 1st quarter valued at approximately $9,055,000. Meadow Creek Wealth Advisors LLC bought a new stake in Veradigm during the 1st quarter valued at approximately $83,000. Vanguard Group Inc. boosted its position in shares of Veradigm by 0.7% in the 4th quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock worth $149,754,000 after purchasing an additional 95,291 shares in the last quarter. Finally, Wellington Management Group LLP boosted its position in shares of Veradigm by 117.8% in the 4th quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after purchasing an additional 3,140,483 shares in the last quarter.

Veradigm Company Profile

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.